Skip to content

Clinical trials

Phase 1/2 Epstein-Barr Virus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epstein-Barr Virus Infections Phase: Phase 1/2 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20081
20121
20131
20142
20161
20171
20181
20192
20201
20211
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Recruiting3
Active, not recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Atara Biotherapeutics2
National Institute of Allergy and Infectious Diseases (NIAID)2
University of Minnesota2
AlloVir1
Baylor College of Medicine1
Children's Hospital Medical Center, Cincinnati1
Cullinan Therapeutics Inc.1
Jessie L. Alexander1
Jessie L. Alexander, MD1
Marengo Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epstein-Barr Virus Infections19
Adenoviridae Infections7
Cytomegalovirus Infections4
Infectious Mononucleosis4
Nasopharyngeal Neoplasms3
Neoplasms3
Carcinoma2
Head and Neck Neoplasms2
Herpes Simplex2
Lymphoma, Large B-Cell, Diffuse2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.